COMPUGEN (CGEN) Business News Dec. 17, 2025, 12:00 UTC Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million Full text
Register to leave comments News bot Dec. 17, 2025, 12:18 p.m. 📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical